We conducted an experiment to compare collagen deposition in tracheal stenoses dilated with room-temperature balloons and stenoses dilated with balloons at a subfreezing temperature (-10°C). Six New Zealand white rabbits underwent endoscopic tracheal injury. Tracheal dilation was performed at 3 weeks postinjury with either a roomtemperature balloon or a vascular cryoplasty balloon. Five surviving rabbits were sacrificed at either 2 weeks (n = 3) or 4 weeks (n = 2) postdilation (1 rabbit that was not able to tolerate dilation was euthanized during the procedure). A blinded pathologist graded histologic sections of the injured tracheas for collagen content. The tracheal collagen deposits in the 3 animals sacrificed at 2 weeks postdilation were all graded as moderate. However, at the 4-week postdilation examination, there was a marked difference in collagen deposition between the rabbit that underwent room-temperature dilation and the rabbit that underwent subfreezing dilation; while the former showed moderate collagen deposition, the deposition in the latter was only mild. In conclusion, this pilot study showed that tracheal dilation with balloon cryotherapy decreased collagen deposition in the injured airway of 1 animal. Larger studies are required to determine whether balloon cryotherapy improves the long-term patency of immature tracheal stenosis.
Abstract
We conducted an experiment to compare collagen deposition in tracheal stenoses dilated with room-temperature balloons and stenoses dilated with balloons at a subfreezing temperature (-10°C) . Six New Zealand white rabbits underwent endoscopic tracheal injury. Tracheal dilation was performed at 3 weeks postinjury with either a roomtemperature balloon or a vascular cryoplasty balloon. Five surviving rabbits were sacrificed at either 2 weeks (n = 3) or 4 weeks (n = 2) postdilation (1 rabbit that was not able to tolerate dilation was euthanized during the procedure). A blinded pathologist graded histologic sections of the injured tracheas for collagen content. The tracheal collagen deposits in the 3 animals sacrificed at 2 weeks postdilation were all graded as moderate. However, at the 4-week postdilation examination, there was a marked difference in collagen deposition between the rabbit that underwent room-temperature dilation and the rabbit that underwent subfreezing dilation; while the former showed moderate collagen deposition, the deposition in Introduction Endoscopic management of tracheal stenosis is most often performed by serial rigid dilation or laser therapy, but these efforts are plagued by restenosis rates of 40 to 80%. [1] [2] [3] The high recurrence rate is most likely attributable to the mucosal and submucosal trauma induced by the treatment itself. Balloon dilation has been advocated because it involves the application of a radial rather than a shearing force to the tracheal wall, which results in only minimal trauma to the mucosal surface and a lower risk of restenosis. This makes balloon dilation a more attractive option. However, when balloon dilation is used alone, it too is associated with high recurrence rates (as high as 80%). 4 Cryotherapy has been added to balloon dilation treatment of the lower extremities in an attempt to improve arterial dilation. Laird et al reported that adding cryotherapy to traditional balloon angioplasty increased clinical patency rates by 10%. 5 The proposed mechanism involves apoptosis of arterial smooth muscle cells after they have been supercooled to -10°C. These smooth muscle cells are responsible for collagen production, and cell death leads to a decreased production of collagen within the arterial wall. 6 The fact that subfreezing temperatures decrease collagen deposition may have direct application to the treatment of tracheal stenosis. To the best of our knowledge, cryotherapy as an adjunct to balloon dilation has not been previously reported in the management of benign tracheal stenosis. ENT-Ear, Nose & Throat Journal  April/May 2013
Materials and methods
The study protocol was approved by the Georgetown University Animal Use and Care Committee, and 6 adult New Zealand white rabbits were housed in individual cages for 8 weeks according to the committee's standards. For each of the procedures, the animal was anesthetized with intramuscular ketamine 25 mg/kg and medetomidine 0.5 mg/kg. Spontaneous respiration was maintained throughout all procedures.
Animals were placed in the supine position in a 43°C warming blanket (Bair Hugger; Arizant; Eden Prairie, Minn.). Direct laryngoscopy was performed with a Wis-Hipple #0 laryngoscope to look for any structural abnormalities. A #3.5 bronchoscope (Karl Storz; Tuttlingen, Germany) with an outer diameter of 5.7 mm was passed into each trachea 1 cm below the cricoid cartilage under telescopic visualization with a 4-mm rigid telescope (Storz). Tracheal injury was performed by passing a 5-mm diameter nylon brush (Key Surgical, Eden Prairie) 2 cm from the end of the bronchoscope four times. The bronchoscope was then rotated 90° to direct the beveled edge of the bronchoscope to the next quadrant. This procedure was repeated until all four quadrants were injured, which took a total of 16 brush strokes.
After this procedure, the animals received 60 ml of lactated Ringer's solution subcutaneously, and a small area of dorsal skin was shaved to prepare it for a 12.5μg/hr transdermal fentanyl patch for postoperative analgesia. The animals then received atipamezole 0.5 mg/kg intramuscularly to induce their emergence from anesthesia.
Endoscopies were performed 2 weeks after injury. The degree of stenosis of the entire airway was graded according to the percentage of luminal narrowing, based on a consensus of 3 study members who viewed the procedure live on a television monitor (table 1) . Endoscopies and stenosis estimates were repeated at 3 weeks postinjury just prior to dilation.
For dilation, the rabbits were divided into two groups:
• Room-temperature dilation. Dilations were performed in 3 animals (rabbits 1, 2, and 3) with a bronchial dilation balloon (Controlled Radial Expansion [CRE] Balloon Dilator; Boston Scientific; Natick, Mass.) to a diameter of 8 mm. The bronchoscope was passed into each trachea under telescopic guidance. Then the telescope was removed from within the bronchoscope, and a CRE balloon was passed through the bronchoscope into the trachea. The bronchoscope was then withdrawn over the balloon, and the telescope was inserted for direct visualization of the balloon placement and dilation. The balloon was inflated with room-temperature saline to a diameter of 8 mm for 30 seconds then deflated and removed immediately.
• Subfreezing dilation. For the remaining 3 animals (rabbits 4, 5, and 6), dilations were performed with a cryoplasty balloon (PolarCath Peripheral Dilation System; Boston Scientific) (figure 1). The administration of general anesthesia, passage of the bronchoscope, and placement of the balloon were all performed in the same manner as in the CRE dilation. The PolarCath balloon was inflated to a diameter of 8 mm for 15 seconds at room temperature and then immediately cooled to -10°C. After 15 seconds, the balloon was deflated and withdrawn, for a total dilation time of 30 seconds.
It was our intention to sacrifice the animals and examine them at either 2 or 4 weeks following dilation.
In all cases, the tracheas and their adjacent esophagi were removed and preserved in 10% neutral buffered formalin. Sections were made through the injured segments of the tracheas, which were then fixed in paraffin blocks. Histology was performed with a trichrome stain to evaluate collagen deposition (figure 2). A blinded pathologist then graded the degree of submucosal collagen deposition as none, mild, moderate, or severe.
Results
The degree of stenosis in the 6 animals 2 weeks after injury ranged from 20 to 80% (mean: 48%) (table 1). Those animals whose stenosis was 40% or greater had audible stridor. With the exception of 1 animal, the degree of stenosis had not changed from week 2 to week 3 postinjury; the exception was rabbit 2, whose stenosis had decreased from 70 to 50%. One animal (rabbit 6) was unable to tolerate the 30-second occlusion time, and it was euthanized during cryodilation. The remaining 5 animals exhibited a 40 to 67% reduction in the degree of stenosis (mean: 51%) at either 2 or 4 weeks (table 1).
The 5 animals that survived the dilation tolerated it without complication. The animal that died had a predilation stenosis of 80%. This animal was in clear respiratory distress after sedation at the time of dilation. On postmortem analysis, its tracheal epithelium had been completely denuded by the cryoballoon at day 0.
In the 5 surviving animals, the epithelium had been completely restored to its normal form by the time of sacrifice. At 2 weeks postdilation, tracheal collagen deposition in the 2 CRE animals (rabbits 1 and 2) and in 1 cryoballoon animal (rabbit 5) was graded as moderate in each case (table 2) . At 4 weeks, there was a marked difference in the degree of deposition between the remaining CRE animal (rabbit 3) and the remaining cryoballoon animal (rabbit 4), as the former was graded moderate and the latter mild. There was no evidence of inflammation or fibrosis of the adjacent esophageal tissues in any of the specimens.
Discussion
Cryotherapy of the tracheobronchial tree has been studied since the 1960s in animals and humans. Canine studies in the 1970s found that complete freezing of the trachea with temperatures as low as -170°C did not cause any architectural loss of the trachea or damage to surrounding structures. 7, 8 In 1977, Rodgers and colleagues demonstrated that the endobronchial application of a cryoprobe to tracheal stenoses in sheep was not only safe but that the lesions healed with minimal submucosal fibrosis. 9 By the 1980s, Rodgers and his group had used a cryoprobe in human patients with benign tracheal stenosis, and they were able to successfully extubate 9 of 10 patients at 2 to 6 years of follow-up. 10 Although somewhat limited in number, studies have shown promise for cryotherapy as both a safe and effective treatment for benign obstructions of the trachea.
Despite the promise of these studies, cryotherapy has never achieved mainstream popularity in treating benign tracheal stenosis. This is due in part to the cumbersome nature of the previously described procedures, which require multiple debridements of previously treated tissues and additional applications of the cryoprobe to persistent scar tissue. 10 However, the largest contributor to the lack of interest in cryotherapy was the rapid advancement and interest in lasers during the 1980s and 1990s. Today, lasers are likely the most common modality used by otolaryngologists to treat tracheal stenosis, either alone or in combination with other modalities. The major criticism of lasers remains the thermal damage they inflict on the treatment area, which often results in additional, persistent scar tissue. This often leads to multiple treatments and may ultimately require tracheal resection. Cryosurgery is a safe therapeutic modality because it creates a well-demarcated lesion with minimal damage to surrounding healthy tissue. This is due to the cryoresistance of cartilage and connective tissue, which is a result of their low water content; mucosal tissue has a high water content and is therefore cryosensitive. 7, 8 The ability of the cryoballoon to dilate the airway while simultaneously treating the scar tissue with subfreezing temperatures could in theory eliminate or at least reduce the need for multiple procedures.
Beyond its safety, cryotherapy has consistently demonstrated a beneficial effect on collagen. When used to treat keloids, cryotherapy reduces collagen deposition, improves collagen structure, and alters fibroblast activity. [11] [12] [13] Knott et al studied cryotherapy in the larynx after endoscopic carbon dioxide laser cordectomy with and without adjuvant therapy with a cryoprobe. 14 They found a reduction in collagen at 2, 6, and 12 weeks after treatment in the adjuvant cryotherapy group, as well as a normalized appearance of the collagen histoarchitecture.
Our study provides additional evidence of the ability of cryotherapy to alter scar formation, which is especially important when treating benign stenosis of the airway. Although limited by a small sample size, our study provides an important descriptive analysis of the effects of the cryoballoon on tissue.
In our animals, the epithelial tissue had regenerated normally by 2 weeks, and there was no histologic evidence of collateral damage by the cryoballoon, thereby demonstrating its safety. The most significant finding was the marked reduction in collagen deposition at 4 weeks after cryoballoon dilation in 1 rabbit. This result, together with previous evidence, speaks again to the potential of cryotherapy in treating benign tracheal stenosis. Coupling cryotherapy with radial balloon dilation may offer an ideal treatment for this historically difficult disease process.
Another limitation of our study was that the small number of animal subjects did not allow us to perform statistical analysis. We plan to repeat this study in a larger cohort of animals.
In conclusion, balloon cryotherapy may decrease collagen deposition in injured airways. In this study, long-term patency of immature tracheal stenosis was improved in 1 animal with the addition of subfreezing temperatures to endoscopic balloon dilation. Future studies with larger sample sizes will allow for quantification and statistical interpretation of the results. 
